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Objective: The aim of this study was to assess the relationship between the two types
of  posttranslational modiﬁcations of proteins in RA: glycosylation on the example of
carbohydrate-deﬁcient transferrin and citrullination by means of autoantibodies to cyclic
citrullinated peptides.
Methods: The study was carried out in 50 RA patients. CDT was measured using N Latex
CDT  immunonephelometric test, the results were presented in absolute and relative units.
Anti-CCP were measured using the chemiluminescent method and rheumatoid factor by
immunoturbidimetric method.
Results: 80% of RA patients were positive for anti-CCP, 70% for RF and 62% for both, anti-
CCP  and RF. The level of %CDT was signiﬁcantly elevated, but absolute CDT level was not
changed. The mean absolute CDT concentration was higher in anti-CCP positive patients
than  that in anti-CCP negative. CDT (absolute and relative concentration) did not correlate
with anti-CCP and RF. However, serum RF signiﬁcantly correlated with anti-CCP. %CDT did
not  correlate with anti-CCP, but absolute level correlated with anti-CCP only in anti-CCP
negative and RF negative patients. CDT did not correlate with RF, but solely with anti-CCP in
anti-CCP negative patients. Anti-CCP correlated with DAS 28 only in anti-CCP negative RA,
but CDT (absolute and relative units) correlated with DAS 28 in all patients and in anti-CCP
positive RA.
Conclusions: These results suggest that the changes in CDT and anti-CCP concentrations
are  not associated with oneself and indicate on the independence of these posttransla-
tional modiﬁcations in rheumatoid arthritis. Only the alterations in transferrin glycosylationPlease cite this article in press as: Gudowska M, et al. Independence of carbohydrate-deﬁcient isoforms of transferrin and cyclic citrullinated
peptides in rheumatoid arthritis. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.01.005
reﬂected the activity of RA.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Independência  de  isoformas  de  transferrina  deﬁciente  em  carboidrato  e
peptídeos  citrulinados  cíclicos  na  artrite  reumatoide
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Objetivo: O objetivo deste estudo foi avaliar a relac¸ão entre os dois tipos de modiﬁcac¸ões
pós-translacionais de proteínas na AR: glicosilac¸ão no caso da transferrina deﬁciente em
carboidrato (TDC) e citrulinac¸ão por meio dos anticorpos no caso do antipeptídeo citrulinado
cíclico (anti-CCP).
Métodos: O estudo foi realizado em 50 pacientes com AR. A TDC foi medida utilizando o
teste imunonefelométrico N Latex CDT, e os resultados foram apresentados em unidades
absolutas e relativas. O anti-CCP foi mensurado usando o método quimioluminescente e o
fator reumatoide (FR) pelo método imunoturbidimétrico.
Resultados: 80% dos pacientes com AR foram positivos para anti-CCP, 70% para FR e 62%
para  ambos (anti-CCP e FR). A percentagem de transferrina total (%TDC) esteve signiﬁcati-
vamente elevada, mas o nível absoluto de TDC não esteve alterado. A concentrac¸ão média
de  TDC absoluta foi maior nos pacientes anti-CCP positivos do que naqueles anti-CCP nega-
tivos. A TDC (concentrac¸ão absoluta e relativa) não se correlacionou com o anti-CCP e o FR.
No  entanto, o FR sérico se correlacionou signiﬁcativamente com o anti-CCP. O percentual
de  TDC não se correlacionou com o anti-CCP, mas seu nível absoluto se correlacionou com
o  anti-CCP apenas em pacientes FR negativos e anti-CCP negativos. A TDC não se correla-
cionou com o FR, somente com o anti-CCP em pacientes anti-CCP negativos. O anti-CCP se
correlacionou com o DAS 28 apenas nos pacientes com AR anti-CCP negativos, mas  a TDC
(unidades absolutas e relativas) se correlacionou com o DAS 28 quando considerados todos
os  pacientes com AR e em pacientes com AR anti-CCP positivos.
Conclusões: Estes resultados sugerem que as alterac¸ões na TDC e as concentrac¸ões de anti-
CCP  não estão associadas entre si e indicam a independência destas modiﬁcac¸ões pós-
translacionais na artrite reumatoide. Apenas as alterac¸ões na glicosilac¸ão da transferrina
reﬂetem a atividade da AR.
© 2016 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC
Bialystok). The diagnosis of RA was conﬁrmed according toIntroduction
Rheumatoid arthritis (RA) is a chronic, autoimmune dis-
ease of connective tissues, with the appearance of several
types of autoantibodies.1 The speciﬁc autoantibodies gener-
ated in RA have been associated with the posttranslational
modiﬁcations of proteins and peptides.2 These modiﬁcation
involve glycosylation, citrullination, methylation, acetylation
and ubiquitination occur in physiological conditions and have
an important role in the normal function of the immune
system.3 The ﬁrst type of autoantibodies founded in RA
patients was rheumatoid factor (RF), which is an autoantibody
to Fc domain of IgG. The changes in glycosylation (galac-
tosylation/sialylation) IgG have been found to be associated
with a pathogenesis of RA and can be diagnostically and
therapeutically useful.4 The several studies were conducted
to recognize the alterations in glycosylation of others glyco-
proteins such as IgA, alpha 1-acid glycoprotein, ﬁbronectin,
haptoglobin and transferrin. Human transferrin exists as an
heterogeneous population glycosylated variants differing in
carbohydrate composition.5 In healthy people mostly occur
tetrasialylated glycoforms and glycoforms which lack one orPlease cite this article in press as: Gudowska M, et al. Independence of ca
peptides in rheumatoid arthritis. Rev Bras Reumatol. 2016. http://dx.doi.o
both of complete N-glycans are called carbohydrate-deﬁcient
transferrin (CDT).5 It has been assumed that CDT is the sum
of three isoforms: asialo-, monosialo- and disialotransferrin.BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The glycosylation of plasma transferrin changes in RA and can
lead to increase the CDT level.6 The newly known posttransla-
tional modiﬁcation in RA is citrullination.7 It is an enzymatic
conversion of arginine to citrulline catalysed by peptidylargi-
nine deiminases (PAD). In patients with RA, PAD may leak out
of the dying cells in the synovial joints which can citrulli-
nate of arginine and generate an cyclic citrullinated peptides
(CCP).8,9 Autoantibodies against CCP are considered as early
diagnostic and prognostic biomarker of RA.10 Their presence
in RA-negative patients testiﬁes for the early RA with worse
prognosis.8 In RA patients many  citrullinated proteins have
been detected, as ﬁbrinogen, vimentin, enolase and type II
collagen.3 The aim of this study was to assess the relationship
between different types of posttranslational modiﬁcations –
glycosylation and citrullination – in RA by means of the con-
centration of CDT and anti-CCP.
Material  and  methods
The study was carried out in 50 RA patients (41 females,
9 males; mean age 53) recruited from the Department of
Rheumatology and Internal Diseases (Medical University inrbohydrate-deﬁcient isoforms of transferrin and cyclic citrullinated
rg/10.1016/j.rbre.2016.01.005
criteria which were set by the American College of Rheuma-
tology (ACR). All patients were interviewed regarding their use
of alcohol. The patients drank alcohol only occasionally.
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Table 1 – The results of laboratory tests in rheumatoid arthritis (RA) patients and controls.
CRP (mg/L) RF (IU/mL) IgG (g/L) CDT (mg/L) %CDT Anti-CCP (U/L)
RA (n = 50) 22.96 ± 25.54
p = 0.000a
172.23 ± 229.37
p < 0.01a
11.79 ± 3.06
p = 0.904
42.70 ± 69.40
p = 0.564
2.03  ± 0.24
p < 0.01a
185.42 ± 325.02
p = 0.000a
Controls (n = 33) 1.04 ± 0.78 21.58 ± 1.23 11.43 ± 1.42 42.52 ± 9.23 1.77 ± 0.22 0.57 ± 0.21
nn–Whitney U test).
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Table 2 – Correlation of CDT with anti-CCP.
Test R  p
All RA
CDT 0.088 0.547
%CDT 0.033 0.821
Anti-CCP positive
CDT −0.212 0.195
%CDT −0.069 0.677
Anti-CCP negative
CDT 0.696 0.025a
%CDT 0.364 0.301
RF positive
CDT −0.063 0.741
%CDT 0.223 0.235
RF negative
CDT 0.629 0.012a
%CDT −0.016 0.954
and high relative CDT concentration. CDT (expressed in both
units) correlated with DAS 28 regardless of anti-CCP levels but
% CDT in RF positive patients. Anti-CCP concentration did not
NegativePositive
Anti-CCP
25
30
35
40
45
50
55
60
65
70
75
CD
T 
[m
g/L
]
P=.022
Mean Mean±SE Mean±SDData are mean and standard deviation.
a p < 0.05 the differences between RA patients and control group (Ma
Control group consisted of 33 healthy subjects (mean age
1) recruited from hospital workers. Blood fasting samples
ere taken by vein puncture after 12 h of fasting. All (healthy
nd sick) subjects gave their informed consent to participate
n the studies. This study was in accordance with the Bioethi-
al Committee at the Medical University in Bialystok and with
he Helsinki Declaration.
RA activity was determined by disease activity score (DAS
8) according to the formula:
AS 28 = 0.56 ∗ sqrt(t28) + 0.28 ∗ sqrt(s28) + 0.7 ∗ ln(ESR)
+ 0.014 ∗ VAS
The number of tender joints (t28), swollen joints (s28),
rythrocyte sedimentation rate (ESR) and visual analogue
cale (VAS) were used in that formula. Low activity of RA
DAS 28 between 2.6 and 3.2) had none of patients, moderate
ctivity (DAS 28 in the range of 3.2–5.1) had 27.08% patients
nd high activity (DAS 28 above 5.1) had 72.92% of patients.
DT was measured using N Latex CDT immunonephelomet-
ic test on BN II analyser (Siemens Healthcare Diagnostics,
omerville, USA). The results were given as absolute CDT
nits (mg/L) and percentage of total transferrin (%CDT).
he antibodies against cyclic citrullinated peptide (anti-CCP)
ere measured on the Architect i2000 analyser. The results
bove 5 U/L are considered negative and ≥5.0 U/L positive.
F (normal values < 30 IU/mL), C-reactive protein (CRP; nor-
al  range: 0.8–1.2 mg/L) and immunoglobulin G (IgG; normal
ange: 5.52–16.31 g/L) were determined using immunoturbidi-
etric methods on the Architect c8000 (Abbott Laboratories,
bbott Park, IL, USA). ESR (mm/h) was measured by Wester-
ren method on the Sediplus S 2000 (Sarstedt, Germany).
tatistical  analysis
he differences between tested and control group were eval-
ated by Mann–Whitney U test. We considered p-values <0.05
s statistically signiﬁcant. The correlation between variables
as assessed using Spearman’s rank correlation coefﬁcient.
esults
he results of laboratory tests in RA patients and controls arePlease cite this article in press as: Gudowska M, et al. Independence of ca
peptides in rheumatoid arthritis. Rev Bras Reumatol. 2016. http://dx.doi.or
resented in Table 1. The mean levels of CRP, RF, %CDT and
nti-CCP were signiﬁcantly higher in RA patients in compari-
on to the control group. 80% of RA patients were positive for
nti-CCP, 70% for RF and 62% for both, anti-CCP and RF.a Signiﬁcant correlation.
CDT concentration did not correlate with anti-CCP in all
RA patients (Table 2), but only in anti-CCP negative (r = 0.696)
and RF negative (r = 0.629) subjects. The comparison of CDT
levels (absolute units) in relation to anti-CCP and RF concen-
trations exhibited the signiﬁcant difference only considering
the anti-CCP levels. In the anti-CCP positive patients, CDT  con-
centration (43.1 ± 7.4 mg/L) was signiﬁcantly higher than in
anti-CCP negative subjects (38.9 ± 2.4 mg/L) (p = 0.022) (Fig. 1).
CDT concentration (absolute and relative units) correlated
with RA activity, it means with DAS 28 in all patients (Table 3).
The high RA activity is associated by the low absolute CDTrbohydrate-deﬁcient isoforms of transferrin and cyclic citrullinated
g/10.1016/j.rbre.2016.01.005
Fig. 1 – Carbohydrate-deﬁcient transferrin (CDT)
concentration in anti-cyclic citrullinated peptides (CCP)
positive and anti-CCP negative patients.
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Table 3 – Correlation of disease activity score (DAS) 28
with anti-CCP and CDT.
Test R p
Correlation between DAS 28 and CDT
All RA patients
CDT −0.350 0.014a
%CDT 0.321 0.026a
Anti-CCP positive
CDT −0.446 0.003a
%CDT 0.324 0.047a
Anti-CCP negative
CDT 0.567 0.112
%CDT 0.627 0.070
RF positive
CDT  −0.306 0.094
%CDT 0.399 0.026a
RF negative
CDT  −0.428 0.144
%CDT 0.319 0.288
Correlation between DAS 28 and anti-CCP
All RA patients 0.050 0.739
Anti-CCP positive 0.193 0.246
Anti-CCP negative 0.748 0.020a
RF positive 0.113 0.550
RF  negative −0.198 0.517
ra Signiﬁcant correlation.
correlate with DAS 28 in all RA patients, but only in anti-CCP
negative subjects.
CDT did not correlate with RF in all RA patients but consid-
ering the anti-CCP and RF values (positive or negative) (p > 0.05
for each comparisons). In contrary, anti-CCP correlated with
RF in all RA subjects (r = 0.348; p = 0.019), and in the anti-CCP
negative subjects (r = 0.750; p = 0.032).
DAS 28 did not differ between anti-CCP positive
(5.63 ± 1.37 U/L) and anti-CCP negative patients (6.14 ±
1.20 U/L) (p = 0.337) and between RF positive (5.84 ± 1.22 U/L)
and RF negative subjects (5.06 ± 1.41 U/L) (p = 0.113). RF
value was signiﬁcantly higher in anti-CCP positive RA
(176 ± 216 IU/mL) than that in anti-CCP negative (142
± 307 IU/mL) (p = 0.047), but anti-CCP did not differ between
RF positive (222 ± 378 U/L) in comparison to RF negative RA
(117 ± 224 U/L) (p = 0.126).
Discussion
The present study demonstrated the lack of association
between concentration of carbohydrate-deﬁcient isoforms
of transferrin (CDT) and the level of citrullinated proteins
and peptides measured by autoantibodies (anti-CCP) in RA
patients. Taking into consideration the relationship of anti-
CCP or CDT with DAS 28, there were only the association
with CDT concentration. Our results are in accordance with
the study of Serdarog˘lu et al.11 and Aridog˘an et al.12 who
proved no signiﬁcant correlation between anti-CCP and DAS
28. Likewise, they did not found a signiﬁcant difference in DAS
28 between anti-CCP negative and anti-CCP positive patients
and between RF positive and RF negative subjects. Similarly,
they found the signiﬁcant differences between anti-CCP pos-
itive and anti-CCP negative RA patients for RF. The only one
study, Önder and co-workers, revealed that anti-CCP were pos-Please cite this article in press as: Gudowska M, et al. Independence of ca
peptides in rheumatoid arthritis. Rev Bras Reumatol. 2016. http://dx.doi.o
itively associated with higher scores of DAS-28, while these
were not associated with ESR and CRP.13 In the other study, a
weak correlation between anti-CCP and DAS 28 was observed, 1 6;x  x x(x x):xxx–xxx
but all RA patients were positive for anti-CCP.14 Although,
there was no correlation between CDT and anti-CCP in RA,
there was association between two serological markers of
RA, it means RF and anti-CCP. CDT correlated with anti-CCP
only in anti-CCP negative and RF negative patients, thus in
seronegative RA. This phenomena may be responsible for sig-
niﬁcantly higher CDT concentration in anti-CCP-positive than
in anti-CCP-negative RA patients. Although, as demonstrated
Aridog˘an et al.,12 antibodies against CCP were more  speciﬁc
for RA than RF (100% vs. 96.8%), anti-CCP did not correlate
with disease activity (DAS 28) but with RF. The diagnostic accu-
racy (area under the ROC curves) of anti-CCP was also higher
than that of RF.15 The lack of correlation of disease activity
with anti-CCP and its existence with CDT may be indicated on
the time-dependent difference in the activity of these two dif-
ferent posttranslational modiﬁcations of the proteins. DAS 28
indicates the current disease activity, but the activation of PAD
and citrullination of various proteins overtakes the clinical
symptoms of disease, but the alterations in transferrin gly-
cosylation undergo parallel with the development of disease.
Hamad et al. also found that the presence of high anti-CCP
level is not associated with higher disease activity.16 However,
anti-CCP positivity and titre correlated with disease duration,
what can enforce our hypothesis about time-dependent shift
in citrullination towards glycosylation in RA. Anti-CCP can be
found early in the course of RA, even years before the onset
of clinical symptoms.17 It is very interesting that the anti-
CCP status may change (from negative to positive and vice
versa) after 3 years from the onset of RA and the mean serum
anti-CCP level declines during the years.18
A major conclusion of this study is that, in RA patients
the changes in transferrin glycosylation measured by means
of carbohydrate-deﬁcient isoforms (CDT) are not related with
citrullination, other type of posttranslational modiﬁcation in
RA.
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